News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arch Biopartners Inc. Announces Change in Year End


11/19/2010 11:53:03 AM

TORONTO, CANADA--(Marketwire - November 19, 2010) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX: ACH)(OTC: FOIFF) announced today that it has changed its financial year end from December 31 to September 30. This change synchronizes Arch's financial reporting with that of its four subsidiaries, which all use September 30 as financial year end.

Arch's most recent financial year ended on December 31, 2009. The change in financial year end means that the Company's next audited financial report will cover the nine month period ending September 30, 2010.

A Notice of Change in Year End will be filed today via SEDAR and will be accessible at www.sedar.com for more information about the change.

About Arch Biopartners

Arch Biopartners is a portfolio based biotechnology company established to develop new products and technology for sale to pharmaceutical and industrial companies.

For more information on the Company, please consult the other public documents filed on SEDAR at www.sedar.com. The Company's website address is: www.archbiopartners.com.

The CNSX has not reviewed and does not accept responsibility for the adequacy of this release.


Contacts:
Arch Biopartners Inc.
Richard Muruve
CEO
(647) 428 7031
info@archbiopartners.com
www.archbiopartners.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES